CTSU/CALGB C30901- Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy

Objective

This randomized phase II trial is studying how well pemetrexed disodium or observation works in treating patients with malignant pleural mesothelioma without progressive disease after first-line chemotherapy. 

http://clinicaltrials.gov/ct2/show/NCT01085630

Location:

Essentia Health Brainerd, Essentia Health Duluth, Essentia Health Fargo

Disclosures:

None

For more information about a financial conflict of interest (FCOI), review the Essentia Health FCOI policy.

Last Updated: 07/09/2012

Research Study Categories

  • Adult Studies

Specialty

  • Cancer
  • Lung Cancer
Contact
Cancer Clinical Trials at 218-786-3308